Multifetal pregnancy reduction: evolution of the ethical arguments
1Comprehensive Genetics, Fetal Medicine Foundation of America, New York, New York 10065, USA. Evans@Compregen.com
Seminars in Reproductive Medicine
|August 5, 2010
Summary
Multifetal pregnancy reduction (MFPR) improves outcomes for higher-order pregnancies. Ethical considerations involve balancing maternal and infant health, prioritizing the least harm for the best results.
Area of Science:
- Reproductive Medicine
- Medical Ethics
Background:
- Multifetal pregnancy reduction (MFPR) was introduced over 20 years ago.
- It aims to improve outcomes in higher-order multifetal pregnancies.
- MFPR is a key component of assisted reproductive technologies.
Observation:
- MFPR is inherently controversial, but ethical viewpoints differ from the typical abortion debate.
- The primary goal is a healthy mother and healthy offspring.
- Reducing the number of fetuses in multifetal pregnancies generally leads to safer outcomes.
Findings:
- Ethical considerations in MFPR are complex, presenting shades of gray rather than clear-cut positions.
- The principle of proportionality is paramount, seeking maximum benefit with minimal harm.
- Moral compromise is often necessary to achieve optimal outcomes.
Implications:
- MFPR presents a nuanced ethical challenge in reproductive medicine.
- The procedure necessitates careful consideration of the principle of proportionality.
- Successful MFPR outcomes prioritize maternal and fetal well-being.
Related Concept Videos
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:08Cloning of Dolly the Sheep
The first successfully cloned mammal was Dolly, a sheep, born on 5th July 1996 at Roslin Institute, Scotland. The cloned sheep was named after the American singer Dolly Parton. Dolly lived for seven years and died of respiratory complications, which is speculated to be due to the actual age of her DNA. Because the DNA in cloned cells belongs to an older individual, the cloned individual’s life expectancy may be affected. Indeed, analysis of Dolly’s DNA revealed shorter telomeres than other...
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...